Edwards Lifesciences (EW) PT, Estimates Lifted at Piper Jaffray Amid Solid Q2
Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted estimates and his price target on Edwards Lifesciences (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
